UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lactoferrin: A Critical Player in Neonatal Host Defense

Nutrients, 2018-09, Vol.10 (9), p.1228

Telang, Sucheta

2018

Volltextzugriff (PDF)

Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer

Experimental and molecular pathology, 2009-06, Vol.86 (3), p.174-179

2009

Volltextzugriff (PDF)

Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis

Cell metabolism, 2014-01, Vol.19 (1), p.37-48

2014

Volltextzugriff (PDF)

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.29-40

2016

Volltextzugriff (PDF)

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1461-1470

2013

Volltextzugriff (PDF)

A quality improvement project improving the value of iNO utilization in preterm and term infants

Journal of perinatology, 2021-01, Vol.41 (1), p.164-172

2021

Volltextzugriff (PDF)

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

Molecular cancer therapeutics, 2008-01, Vol.7 (1), p.110-120

2008

Volltextzugriff (PDF)

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

Oncogene, 2021-06, Vol.40 (25), p.4384-4397

2021

Volltextzugriff (PDF)

Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases

The Journal of biological chemistry, 2009-09, Vol.284 (36), p.24223-24232

2009

Volltextzugriff (PDF)

Targeting aspartate aminotransferase in breast cancer

Breast cancer research : BCR, 2008-01, Vol.10 (5), p.R84-R84, Article R84

2008

Volltextzugriff (PDF)

Targeting Resistance in Medulloblastoma

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

Journal of translational medicine, 2012-05, Vol.10 (1), p.95-95, Article 95

2012

Volltextzugriff (PDF)

Disruption of Inducible 6-Phosphofructo-2-kinase Ameliorates Diet-induced Adiposity but Exacerbates Systemic Insulin Resistance and Adipose Tissue Inflammatory Response

The Journal of biological chemistry, 2010-02, Vol.285 (6), p.3713-3721

2010

Volltextzugriff (PDF)

Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype

Cell stem cell, 2009-04, Vol.4 (4), p.336-347

2009

Volltextzugriff (PDF)

Transient T cell depletion causes regression of melanoma metastases

Journal of translational medicine, 2008-03, Vol.6 (1), p.12-12, Article 12

2008

Volltextzugriff (PDF)

The oncoprotein H-RasV12 increases mitochondrial metabolism

Molecular cancer, 2007-12, Vol.6 (1), p.77-77, Article 77

2007

Volltextzugriff (PDF)

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

BMC cancer, 2011-12, Vol.11 (1), p.515-515, Article 515

2011

Volltextzugriff (PDF)

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism

Cancer & metabolism, 2014-01, Vol.2 (1), p.2-2, Article 2

2014

Volltextzugriff (PDF)

Abstract 2171 Targeting Sugar Metabolism in Breast Cancer

The Journal of biological chemistry, 2024-03, Vol.300 (3), p.106483, Article 106483

2024

Volltextzugriff (PDF)

Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model

Neoplasia (New York, N.Y.), 2007-01, Vol.9 (1), p.47-56

2007

Volltextzugriff (PDF)

Targeting Glucose Metabolism in HER2+ Breast Cancer

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.04253

2021

Volltextzugriff (PDF)

Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non–small cell lung cancer cell survival

The Journal of biological chemistry, 2019-07, Vol.294 (27), p.10530-10543

2019

Volltextzugriff (PDF)

Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth

Molecular cancer, 2012-08, Vol.11 (1), p.60-60, Article 60

2012

Volltextzugriff (PDF)

Targeting Glucose Metabolism in Medulloblastoma

The FASEB journal, 2019-04, Vol.33 (S1), p.652.19-652.19

2019

Volltextzugriff (PDF)

Abstract 2519: Targeting glucose metabolism in HER2+breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2519-2519

2021

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(76)

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(41)
Humans
(28)
Animals
(24)
Mice
(20)
Glycolysis
(19)
Oncology
(18)
Female
(15)
Phosphofructokinase-2 - Metabolism
(13)
Biochemistry & Molecular Biology
(12)
Cell Biology
(11)
Cell Line, Tumor
(11)
Phosphofructokinase-2 - Antagonists & Inhibitors
(10)
Phosphofructokinase-2 - Genetics
(10)
Cancer
(9)
Biological And Medical Sciences
(8)
Glucose Metabolism
(8)
Metabolism
(8)
Mice, Nude
(8)
6-Phosphofructo-2-Kinase
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lactoferrin: A Critical Player in Neonatal Host Defense

Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer

Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

A quality improvement project improving the value of iNO utilization in preterm and term infants

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases

Targeting aspartate aminotransferase in breast cancer

Targeting Resistance in Medulloblastoma

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

Disruption of Inducible 6-Phosphofructo-2-kinase Ameliorates Diet-induced Adiposity but Exacerbates Systemic Insulin Resistance and Adipose Tissue Inflammatory Response

Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype

Transient T cell depletion causes regression of melanoma metastases

The oncoprotein H-RasV12 increases mitochondrial metabolism

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism

Abstract 2171 Targeting Sugar Metabolism in Breast Cancer

Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model

Targeting Glucose Metabolism in HER2+ Breast Cancer

Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non–small cell lung cancer cell survival

Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth

Targeting Glucose Metabolism in Medulloblastoma

Abstract 2519: Targeting glucose metabolism in HER2+breast cancer

Suchergebnisse filtern